Axe Compute Inc.

For the period ended Dec 31, 2025. Filed Mar 31, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 31, 2026

AGPU$7.64+1.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholders’ Equity (Deficit)

FOR THE YEARS ENDED

DECEMBER 31, 2025 AND 2024

Series B Preferred · Common Stock · Additional Paid-In · Accumulated
	Shares	Amount	Shares	Amount	Capital	Deficit	Total
Balance at December 31, 2023	79,246	$792	270,863	$2,709	$176,030,162	$(167,761,883)	$8,271,780
Issuance of shares to non-employees	-	-	2,597	26	99,227	-	99,253
Issuance of shares pursuant to At-The-Market financing, net of issuance costs	-	-	107,140	1,071	3,120,931	-	3,122,002
Issuance of shares pursuant to Warrant Inducement Transaction, net of issuance costs	-	-	63,875	639	966,961	-	967,600
Stock-based compensation, net of forfeitures	-	-	-	-	1,143	-	1,143
Net loss	-	-	-	-	-	(12,664,388)	(12,664,388)
Balance at December 31, 2024	79,246	$792	444,475	$4,445	$180,218,424	$(180,426,271)	$(202,610)
Issuance of common stock pursuant to warrant exercises	-	-	739,508	7,395	1,598,532	-	1,605,927
Issuance of common stock pursuant to Registered Direct Offering, net of issuance costs	-	-	24,223	242	465,063	-	465,305
Issuance of common stock pursuant to Renovaro Extension Agreement	-	-	31,153	312	499,688	-	500,000
Issuance of common stock to non-employees as compensation	-	-	6,667	67	99,933	-	100,000
Issuance of common stock pursuant to At The Market Offering, net of issuance costs	-	-	139,680	1,397	1,528,826	-	1,530,223
Issuance of common stock pursuant to May 2025 private placement	-	-	18,692	187	299,813	-	300,000
Issuance of common stock pursuant to Yorkville SEPA commitment fee	-	-	8,033	80	99,920	-	100,000
Issuance of common stock pursuant to August 2025 private placement	-	-	36,237	362	412,731	-	413,093
Round up of fractional shares pursuant to reverse stock split	-	-	72,745	727	(727)	-	-
Issuance of shares and pre-funded warrants pursuant to October 2025 private placements, net of issuance costs	-	-	2,511,552	25,116	259,650,812	-	259,675,928
Issuance of warrants to DNA Holdings Venture pursuant to Strategic Advisor Agreement	-	-	-	-	15,350,146	-	15,350,146
Issuance of common stock in connection with restricted stock units vesting	-	-	50,208	502	(58,871)	-	(58,369)
Stock-based compensation, net of forfeitures	-	-	-	-	1,032,515	-	1,032,515
Net loss	-	-	-	-	-	(233,095,203)	(233,095,203)
Balance at December 31, 2025	79,246	$792	4,083,173	$40,832	$461,196,805	$(413,521,474)	$47,716,955

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.